High Content Screening Market, By Product Type (Cell Imaging and Analysis Equipment, Consumables, HCS Software, HCS Services), By Application (Primary Screening, Target Identification & Validation, Toxicity Studies, Compound Profiling, Others), By End Use

High Content Screening Market, By Product Type (Cell Imaging and Analysis Equipment, Consumables, HCS Software, HCS Services), By Application (Primary Screening, Target Identification & Validation, Toxicity Studies, Compound Profiling, Others), By End User (Pharmaceutical Organizations, Biotechnology Organizations, Research Institutes, Independent CRO, Government Organizations, Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

High content screening involves identification of substances such as peptides, small molecules, and others and how they affects phenotype of a cell. High content screening is used in biological research and drug discovery. It involves incubations of cells with a substance or a drug candidate, and later the structure and molecular components of the cells are analyzed. Accelerating drug development has become a crucial factor so as to come up with new and advanced drugs that has potential to treat cancer. Understanding the cellular functionality of these oncogenic substances and tumor cells is thus a very important step in the drug development and requires high-powered microscopes to understand the dynamic structures so as to develop a drug against the cancer causing agents.
Restraints of the Global High Content Screening Market
Factors such as high costs of the high content screening equipment, and limited presence in emerging economies in the Asia Pacific region is expected to hinder growth of the market. Image analysis for HCS is a time-consuming and labor-intensive process, which is also expected to hinder growth of the market.
Key features of the study:
This report provides in-depth analysis of the global high content screening market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global high content screening market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Becton, Dickinson and Company, Thermo Fisher Scientific Inc., GE Healthcare, Olympus Corporation, PerkinElmer Inc., Merck Millipore Corporation, Danaher Corporation (Molecular Devices), Yokogawa Electric Corporation, Sysmex Corporation, and Thorlabs, Inc.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global high content screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global High Content Screening Market, By Product Type:
Cell Imaging and Analysis Equipment
Consumables
HCS Software
HCS Services
Global High Content Screening Market, By Application:
Primary Screening
Target Identification & Validation
Toxicity Studies
Compound Profiling
Others
Global High Content Screening Market, By End User:
Pharmaceutical Organizations
Biotechnology Organizations
Research Institutes
Independent CRO
Government Organizations
Others
Global High Content Screening Market, By Geography:
North America
By Product Type
Cell Imaging and Analysis Equipment
Consumables
HCS Software
HCS Services
Application
Primary Screening
Target Identification & Validation
Toxicity Studies
Compound Profiling
Others
By End User
Pharmaceutical Organizations
Biotechnology Organizations
Research Institutes
Independent CRO
Government Organizations
Others
By Country:
U.S.
Canada
Europe
By Product Type
Cell Imaging and Analysis Equipment
Consumables
HCS Software
HCS Services
Application
Primary Screening
Target Identification & Validation
Toxicity Studies
Compound Profiling
Others
By End User
Pharmaceutical Organizations
Biotechnology Organizations
Research Institutes
Independent CRO
Government Organizations
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type
Cell Imaging and Analysis Equipment
Consumables
HCS Software
HCS Services
Application
Primary Screening
Target Identification & Validation
Toxicity Studies
Compound Profiling
Others
By End User
Pharmaceutical Organizations
Biotechnology Organizations
Research Institutes
Independent CRO
Government Organizations
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product Type
Cell Imaging and Analysis Equipment
Consumables
HCS Software
HCS Services
Application
Primary Screening
Target Identification & Validation
Toxicity Studies
Compound Profiling
Others
By End User
Pharmaceutical Organizations
Biotechnology Organizations
Research Institutes
Independent CRO
Government Organizations
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Product Type
Cell Imaging and Analysis Equipment
Consumables
HCS Software
HCS Services
Application
Primary Screening
Target Identification & Validation
Toxicity Studies
Compound Profiling
Others
By End User
Pharmaceutical Organizations
Biotechnology Organizations
Research Institutes
Independent CRO
Government Organizations
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type
Cell Imaging and Analysis Equipment
Consumables
HCS Software
HCS Services
Application
Primary Screening
Target Identification & Validation
Toxicity Studies
Compound Profiling
Others
By End User
Pharmaceutical Organizations
Biotechnology Organizations
Research Institutes
Independent CRO
Government Organizations
Others
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Becton, Dickinson and Company *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Thermo Fisher Scientific Inc.
GE Healthcare
Olympus Corporation
PerkinElmer Inc.
Merck Millipore Corporation
Danaher Corporation (Molecular Devices)
Sysmex Corporation
Thorlabs, Inc.
“*” marked represents similar segmentation in other categories in the respective section.